Gaxos.AI Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $6M+149,019.7% YoYTTM through 30 Jun 2026
Net Income -$3.9MTTM through 30 Jun 2026
Free Cash Flow -$5.4MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| EBITDA Margin | -113.6% |
| Operating Margin | -254.9% |
| Net Margin | -64.8% |
Returns
-33.6%ROE
-31.9%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio21.00x
Net Debt-$12.2Mnet cash position
Cash & Equivalents$1.1M
Quality Metrics
Altman Z-Score26.30
Piotroski F-Score1 / 9
FCF Margin-90.3%
Rule of 40-73.1
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $1.9M
Diluted EPS-$0.48TTMFY2025: $-0.55
Dividend
No dividend
Capital Allocation
R&D Spend$1.5M
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| RNK Health | $1.2M | View detailsRNK Health operates as a 70%-owned subsidiary of Gaxos.ai Inc. and represents a major driver of early commercial traction. | |
| AI Applications | $563.5K | View detailsEarly commercialization phase with rapid subscription growth driven by marketing campaigns. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.